| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.5 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |